Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 73

Sort by

Sort Order Select

Journal Articles

Autoimmune and Inflammatory Diseases in Children with Sickle Cell Disease: A French Multicenter Observational Study on Diagnostic and Therapeutic Issues

Blood (2024) 144 (Supplement 1): 1117.

https://doi.org/10.1182/blood-2024-208048

Published: 2024

Journal Articles

Durable Clinical Benefits with Exagamglogene Autotemcel for Severe Sickle Cell Disease

Blood (2024) 144 (Supplement 1): 4954.

https://doi.org/10.1182/blood-2024-204001

Published: 2024

Journal Articles

Oxygen Gradient Ektacytometry Is Associated with Markers of Hemolysis and Inflammation in a Large Sickle Cell Disease Cohort within the GenoMed4ALL Project

Blood (2024) 144 (Supplement 1): 290.

https://doi.org/10.1182/blood-2024-200639

Published: 2024

Journal Articles

Data Driven Research through the European RADeep Registry and the Use of Artificial Intelligence Towards Personalized Medicine in Sickle Cell Disease

Blood (2024) 144 (Supplement 1): 1138.

https://doi.org/10.1182/blood-2024-203331

Published: 2024

Journal Articles

Exagamglogene Autotemcel for Severe Sickle Cell Disease

Blood (2023) 142 (Supplement 1): 1052.

https://doi.org/10.1182/blood-2023-190139

Published: 2023

Journal Articles

Availability and Cost of Basic Drugs for Sickle Cell Disease in 13 African Countries

Gladys Kelly Keza, Dapa Aly Diallo, Ibrahima Diagne, Mariane de Montalembert, Anne Corbasson, Françoise Bernaudin, Brigitte Ranque, Binta Coulibaly, Galacteros Frederic, Saliou Diop, Constant Vodouhé, Olivier Hermine, Agnès Lainé, Eléonor Kafando, Ahoefa Vovor, Sébastien Jan, Leon Tshilolo, Robert Hue, Jean-Benoit Arlet

Blood (2023) 142 (Supplement 1): 1152.

https://doi.org/10.1182/blood-2023-188652

Published: 2023

Journal Articles

Safety Profile of Crizanlizumab 5.0 Mg/Kg in Sickle Cell Disease: Pooled Data from Clinical Trials

Abdullah Kutlar, Vikas Joshi, Andreas Brueckner, Julie Kanter, Darla K. Liles, Jeremie Lincy, Rahul Manjare, Yvonne Dei Adomakoh, Matthew M. Heeney, Mariane de Montalembert, Deborah Keefe, Kwaku Marfo, Kenneth I. Ataga

Blood (2023) 142 (Supplement 1): 1139.

https://doi.org/10.1182/blood-2023-188639

Published: 2023

Journal Articles

The Cs a and Cs b Red Cell Antigens of the Cost Blood Group Collection Correspond to the HNA-3a and HNA-3b Neutrophil Antigens: Unexpected Twins with Implications for Sickle Cell Anemia

Jonathan De Oliveira Rios, Alisa Soudry, Romain Duval, Alexandre Raneri, Thomas Poyot, Jérome Babinet, Mariane De Montalembert, Claudia Regina Bonini Domingos, Caroline Le Van Kim, Marc Romana, Thierry Peyrard, Slim Azouzi

Blood (2023) 142 (Supplement 1): 698.

https://doi.org/10.1182/blood-2023-178250

Published: 2023

Journal Articles

Efficacy, Safety, and Biomarker Analysis of 5 Mg and 7.5 Mg Doses of Crizanlizumab in Patients with Sickle Cell Disease: Primary Analyses from the Phase III STAND Study

Miguel R Abboud, Rodolfo D Cançado, Mariane De Montalembert, Wally R Smith, Hala Rimawi, Ersi Voskaridou, Birol Guvenc, Deborah Keefe, Kai Grosch, Michele L Nassin, Jimmy Watson, Justin Yssel, Evgeniya Reshetnyak, Yvonne Dei Adomakoh

Blood (2023) 142 (Supplement 1): 272.

https://doi.org/10.1182/blood-2023-185429

Published: 2023

Journal Articles

Sickle Cell Health Awareness, Perspectives, and Experiences (SHAPE) Survey: Findings on the Burden of Sickle Cell Disease and Impact on the Quality of Life of Patients and Caregivers in Gulf Cooperation Council Countries

Wasil Jastaniah, Regina Hartfield, John James, Biba Tinga, Elvie Ingoli, Mariane de Montalembert, Fernando F. Costa, Alan Randall Anderson, Joachim B. Kunz, Isaac Odame, Belinda Lartey, Baba P.D. Inusa

Blood (2023) 142 (Supplement 1): 2516.

https://doi.org/10.1182/blood-2023-177655

Published: 2023

Journal Articles

Sickle Cell Health Awareness, Perspectives, and Experiences (SHAPE) Survey: Perspectives of Physicians in Gulf Cooperation Council Countries on Sickle Cell Disease

Wasil Jastaniah, Mariane de Montalembert, Fernando F. Costa, Alan Randall Anderson, Joachim B. Kunz, Isaac Odame, Belinda Lartey, Baba P.D. Inusa

Blood (2023) 142 (Supplement 1): 5309.

https://doi.org/10.1182/blood-2023-177685

Published: 2023

Journal Articles

Puberty Onset and Preservation of Fertility in Male Patients with Sickle Cell Disease Treated with Hydroxyurea: Data from the European Sickle Cell Disease Cohort - Hydroxyurea Extension (ESCORT-HU Extension) Study

Mariane De Montalembert, Pablo Bartolucci, Gonzalo De Luna, Anoosha Habibi, Scylia Alexis-Fardini, Maryse Etienne-Julan, Gylna Loko, Giovanna Cannas, Jean-Benoit Arlet, Latifatou Boukari, Sylvain Le Jeune, Laure Joseph

Blood (2023) 142 (Supplement 1): 145.

https://doi.org/10.1182/blood-2023-178219

Published: 2023

Journal Articles

Efficacy and Safety of a Single Dose of Exagamglogene Autotemcel for Severe Sickle Cell Disease

Haydar Frangoul, Franco Locatelli, Monica Bhatia, Markus Y. Mapara, Lyndsay Molinari, Akshay Sharma, Stephan Lobitz, Mariane de Montalembert, Damiano Rondelli, Martin Steinberg, Mark C. Walters, Suzan Imren, Lanju Zhang, Anjali Sharma, Yang Song, Christopher Simard, William Hobbs, Stephen Grupp

Blood (2022) 140 (Supplement 1): 29–31.

https://doi.org/10.1182/blood-2022-162353

Published: 2022

Journal Articles

Hydroxyurea Is Associated with Later Onset of Occurrence of Acute Splenic Sequestration Episodes in Sickle Cell Disease: Lessons from the European Sickle Cell Disease Cohort - Hydroxyurea (ESCORT-HU) Study

Mariane de Montalembert, Frédéric Galactéros, Lena Oevermann, Giovanna Cannas, Laure Joseph, Gylna Loko, Narcisse Elenga, Malika Benkerrou, Maryse Etienne-Julan, Marie-Pierre Castex, Regine Grosse, Valentine Brousse

Blood (2022) 140 (Supplement 1): 449–450.

https://doi.org/10.1182/blood-2022-165946

Published: 2022

Journal Articles

Sputum IL-6 Level Is a Potential Predictor and Severity Marker of Acute Chest Syndrome in Sickle Cell Disease

Slimane Allali, Juliette Elie, Mariane de Montalembert, Melissa Taylor, Joséphine Brice, Stéphanie Chhun, Rachel Rignault-Bricard, Claire Heilbronner, Thiago Trovati Maciel, Olivier Hermine

Blood (2022) 140 (Supplement 1): 8265.

https://doi.org/10.1182/blood-2022-166823

Published: 2022

Journal Articles

HbS promotes TLR4-mediated monocyte activation and proinflammatory cytokine production in sickle cell disease

Slimane Allali, Rachel Rignault-Bricard, Mariane de Montalembert, Melissa Taylor, Tahar Bouceba, Olivier Hermine, Thiago Trovati Maciel

Blood (2022) 140 (18): 1972–1982.

https://doi.org/10.1182/blood.2021014894

Published: 2022

Includes: Supplemental data

Journal Articles

Limited Access to Transcranial Doppler Screening and Stroke Prevention for Children with Sickle Cell Disease in Europe: Results of a Multinational Eurobloodnet Survey

Daniela Cuzzubbo, Victoria Gutierrez-Valle, Maddalena Casale, Vincenzo Voi, Corrina McMahon, Maria Del Mar Mañú Pereira, Mariane de Montalembert, Baba PD Inusa, Raffaella Colombatti

Blood (2021) 138 (Supplement 1): 915.

https://doi.org/10.1182/blood-2021-147298

Published: 2021

Journal Articles

Implementation of Escort-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension Study : Interests and Methodology

Mariane de Montalembert, Ersi Voskaridou, Lena Oevermann, Giovanna Cannas, Anoosha Habibi, Gylna Loko, Laure Joseph, Raffaella Colombatti, Pablo Bartolucci, Valentine Brousse, Frédéric Galactéros

Blood (2021) 138 (Supplement 1): 3098.

https://doi.org/10.1182/blood-2021-152525

Published: 2021

Journal Articles

Experiences of Sickle Cell Disease (SCD) Reported By Healthcare Professionals (HCPs) across Different Regions: International Sickle Cell World Assessment Survey (SWAY)

Blood (2021) 138 (Supplement 1): 3026.

https://doi.org/10.1182/blood-2021-145409

Published: 2021

Journal Articles

ERN-EuroBloodNet European Registry of Patients Affected by Red Blood Cell Disorders and COVID-19

Pablo Velasco, Filomena Longo, Andrea Piolatto, Eduardo J. Bardón-Cancho, Beatriz Ponce-Salas, Pagona Flevari, Ersi Voskaridou, Bart J. Biemond, Erfan Nur, Polyxeni Delaporta, Tatiana Besse-Hammer, Anna Ruiz-Llobet, Simona Raso, Anna Spasiano, Maria Elena Guerzoni, David Beneitez-Pastor, Laurence Dedeken, Alessia Pepe, Rosamaria Rosso, Joachim B. Kunz, Mariane de Montalembert, Saveria Campisi, Andreas Glenthøj, Paula Gonzalez Urdiales, Fleur Samantha Benghiat, Marie-Agnès Azerad, Christopher J. Saunders, Teresa Ferreira Faria, Tommaso Casini, Sabrina Bagnato, Ann Van de Velde, Veerle Labarque, Elisa Bertoni, An Van Damme, Michael D. Diamantidis, Roberta Russo, Eftichia Stiakaki, Alessandra Quota, Soteroula Christou, Maria Jose Teles, Ioannis Lafiatis, Jean-Louis Kerkhoffs, María Argüello Marina, Mikael Lorite, Alexis Rodriguez, Achille Iolascon, Ali T. Taher, Raffaella Colombatti, Noemi Roy, Maria Del Mar Mañú Pereira

Blood (2021) 138 (Supplement 1): 4058.

https://doi.org/10.1182/blood-2021-147236

Published: 2021

NARROW

Autoimmune and Inflammatory Diseases in Children with Sickle Cell Disease: A French Multicenter Observational Study on Diagnostic and Therapeutic Issues

Durable Clinical Benefits with Exagamglogene Autotemcel for Severe Sickle Cell Disease

Oxygen Gradient Ektacytometry Is Associated with Markers of Hemolysis and Inflammation in a Large Sickle Cell Disease Cohort within the GenoMed4ALL Project

Data Driven Research through the European RADeep Registry and the Use of Artificial Intelligence Towards Personalized Medicine in Sickle Cell Disease

Exagamglogene Autotemcel for Severe Sickle Cell Disease

Availability and Cost of Basic Drugs for Sickle Cell Disease in 13 African Countries

Safety Profile of Crizanlizumab 5.0 Mg/Kg in Sickle Cell Disease: Pooled Data from Clinical Trials

The Cs a and Cs b Red Cell Antigens of the Cost Blood Group Collection Correspond to the HNA-3a and HNA-3b Neutrophil Antigens: Unexpected Twins with Implications for Sickle Cell Anemia

Efficacy, Safety, and Biomarker Analysis of 5 Mg and 7.5 Mg Doses of Crizanlizumab in Patients with Sickle Cell Disease: Primary Analyses from the Phase III STAND Study

Sickle Cell Health Awareness, Perspectives, and Experiences (SHAPE) Survey: Findings on the Burden of Sickle Cell Disease and Impact on the Quality of Life of Patients and Caregivers in Gulf Cooperation Council Countries

Sickle Cell Health Awareness, Perspectives, and Experiences (SHAPE) Survey: Perspectives of Physicians in Gulf Cooperation Council Countries on Sickle Cell Disease

Puberty Onset and Preservation of Fertility in Male Patients with Sickle Cell Disease Treated with Hydroxyurea: Data from the European Sickle Cell Disease Cohort - Hydroxyurea Extension (ESCORT-HU Extension) Study

Efficacy and Safety of a Single Dose of Exagamglogene Autotemcel for Severe Sickle Cell Disease

Hydroxyurea Is Associated with Later Onset of Occurrence of Acute Splenic Sequestration Episodes in Sickle Cell Disease: Lessons from the European Sickle Cell Disease Cohort - Hydroxyurea (ESCORT-HU) Study

Sputum IL-6 Level Is a Potential Predictor and Severity Marker of Acute Chest Syndrome in Sickle Cell Disease

HbS promotes TLR4-mediated monocyte activation and proinflammatory cytokine production in sickle cell disease

Limited Access to Transcranial Doppler Screening and Stroke Prevention for Children with Sickle Cell Disease in Europe: Results of a Multinational Eurobloodnet Survey

Implementation of Escort-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension Study : Interests and Methodology

Experiences of Sickle Cell Disease (SCD) Reported By Healthcare Professionals (HCPs) across Different Regions: International Sickle Cell World Assessment Survey (SWAY)

ERN-EuroBloodNet European Registry of Patients Affected by Red Blood Cell Disorders and COVID-19

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only